Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia

Summary

Due to limited data regarding preeclampsia from the local population, the debate is still ongoing in the study setting. Hence, the current study was planned to compare the efficacy of labetalol and hydralazine for the treatment of hypertension in patients with severe preeclampsia.

Timeline

Start

2024-05-01

Primary completion

2024-10-31

Completion

2024-10-31

Drugs

Indications